To The Moon
Home
News
TigerAI
Log In
Sign Up
DesmondChin
+Follow
Posts · 501
Posts · 501
Following · 0
Following · 0
Followers · 0
Followers · 0
DesmondChin
DesmondChin
·
2023-12-01
Still depending on FreeFire? Anything else other than that? How about their expansion in EU and Latin?
I'm Cautiously Optimistic About Sea Limited's Gaming Business Turnaround. Here's Why
Garena is set for better times ahead in the coming months.
I'm Cautiously Optimistic About Sea Limited's Gaming Business Turnaround. Here's Why
看
2.16K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
DesmondChin
DesmondChin
·
2022-06-13
Just went into their livestreaming channel, 100k+ viewers at all time and their fans subscriptions had passed 15mil
Sorry, this post has been deleted
看
2.34K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
DesmondChin
DesmondChin
·
2022-05-30
Lol crap, good day for Chinese ADRs but the market closed..
Reminder: U.S. Market Will Be Closed on May 30 for Memorial Day
Memorial Day is around the corner. The U.S. market will be closed on Monday, 30 May 2022. Please tak
Reminder: U.S. Market Will Be Closed on May 30 for Memorial Day
看
2.24K
回复
Comment
点赞
2
编组 21备份 2
Share
Report
DesmondChin
DesmondChin
·
2021-09-24
Chances are high since we experience it once before
Sorry, this post has been deleted
看
2.94K
回复
1
点赞
1
编组 21备份 2
Share
Report
DesmondChin
DesmondChin
·
2021-09-23
Apple was and would still be a big bully. But in this case, fully support what apple did you can't just come to someone house and demand/do whatever you want, this is not freedom/freewill but act of hooligan
Sorry, this post has been deleted
看
1.95K
回复
Comment
点赞
1
编组 21备份 2
Share
Report
DesmondChin
DesmondChin
·
2021-09-23
New kid on the block
Salesforce rival Freshworks valued at over $12 billion as shares jump in U.S. debut
Enterprise software maker Freshworks Inc was valued at $12.2 billion in its Nasdaq debut on Wednesda
Salesforce rival Freshworks valued at over $12 billion as shares jump in U.S. debut
看
2.43K
回复
3
点赞
1
编组 21备份 2
Share
Report
DesmondChin
DesmondChin
·
2021-09-23
The whole industry FM said bubble and you say no.... Well, you really one of a kind
Sorry, this post has been deleted
看
3.21K
回复
1
点赞
4
编组 21备份 2
Share
Report
DesmondChin
DesmondChin
·
2021-09-21
Safe for 5-11 but I have another kid at 2...
Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in kids
Sept 20 (Reuters) - Pfizer Inc and BioNTech SE said on Monday their COVID-19 vaccine induced a robus
Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in kids
看
1.79K
回复
Comment
点赞
Like
编组 21备份 2
Share
Report
DesmondChin
DesmondChin
·
2021-09-21
Overhyped stock
Sorry, this post has been deleted
看
2.37K
回复
1
点赞
Like
编组 21备份 2
Share
Report
DesmondChin
DesmondChin
·
2021-09-21
Lol, anything bout gambling then MJ would be keen
Sorry, this post has been deleted
看
1.98K
回复
Comment
点赞
1
编组 21备份 2
Share
Report
Load more
Most Discussed
{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3578983795474363","uuid":"3578983795474363","gmtCreate":1615892601931,"gmtModify":1617967802157,"name":"DesmondChin","pinyin":"desmondchin","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/b90cb6b6a6c328ac8d02a829e5e7c835","hat":"https://static.tigerbbs.com/46b6808e1ba3716fb9c53339adffa3c5","hatId":"1643427577754_head_frame","hatName":"goods_118_name","vip":1,"status":2,"fanSize":53,"headSize":586,"tweetSize":501,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.04.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.17","exceedPercentage":"60.78%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":4,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":247275226742800,"gmtCreate":1701407955868,"gmtModify":1701407960243,"author":{"id":"3578983795474363","authorId":"3578983795474363","name":"DesmondChin","avatar":"https://static.tigerbbs.com/b90cb6b6a6c328ac8d02a829e5e7c835","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578983795474363","idStr":"3578983795474363"},"themes":[],"htmlText":"Still depending on FreeFire? Anything else other than that? How about their expansion in EU and Latin? ","listText":"Still depending on FreeFire? Anything else other than that? How about their expansion in EU and Latin? ","text":"Still depending on FreeFire? Anything else other than that? How about their expansion in EU and Latin?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/247275226742800","repostId":"2387340714","repostType":2,"repost":{"id":"2387340714","kind":"highlight","pubTimestamp":1701331724,"share":"https://ttm.financial/m/news/2387340714?lang=&edition=fundamental","pubTime":"2023-11-30 16:08","market":"us","language":"en","title":"I'm Cautiously Optimistic About Sea Limited's Gaming Business Turnaround. Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2387340714","media":"Motley Fool","summary":"Garena is set for better times ahead in the coming months.","content":"<div>\n<p>Once a gem within Singapore tech conglomerate Sea Limited, Garena has fallen from grace as revenue and profitability declined massively over the last few quarters. It didn't help that this game ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/11/29/im-cautiously-optimistic-about-sea-gaming-business/\">Web Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>I'm Cautiously Optimistic About Sea Limited's Gaming Business Turnaround. Here's Why</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nI'm Cautiously Optimistic About Sea Limited's Gaming Business Turnaround. Here's Why\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-11-30 16:08 GMT+8 <a href=https://www.fool.com/investing/2023/11/29/im-cautiously-optimistic-about-sea-gaming-business/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Once a gem within Singapore tech conglomerate Sea Limited, Garena has fallen from grace as revenue and profitability declined massively over the last few quarters. It didn't help that this game ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/11/29/im-cautiously-optimistic-about-sea-gaming-business/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SE":"Sea Ltd"},"source_url":"https://www.fool.com/investing/2023/11/29/im-cautiously-optimistic-about-sea-gaming-business/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2387340714","content_text":"Once a gem within Singapore tech conglomerate Sea Limited, Garena has fallen from grace as revenue and profitability declined massively over the last few quarters. It didn't help that this game development business had to temporarily halt its operations of Freefire apps in India due to a regulatory ban.However, the tide could now be turning. For starters, the Indian regulator recently lifted that ban. And after a few quarters of highly challenging times, there are early signs that Garena might have reached a bottom.Garena's key performance metrics have stabilizedGarena was already doing well, but when the COVID-19 pandemic hit, demand went through the roof amid global lockdowns. For perspective, quarterly active users (QAU) totaled 355 million in the fourth quarter of 2019, but more than doubled to a peak of 729 million in the third quarter of 2021. Similarly, bookings more than doubled from $512 million to $1.2 billion during that period.But good times did not last long for Garena as demand for its games could not sustain momentum in the post-pandemic period. Bookings peaked at $1.2 billion per quarter in the third quarter of 2021 and have declined to a low of $443 million in the second quarter of 2023. Similarly, QAU fell precipitously to a low of 486 million in the fourth quarter of 2022.Investors were disappointed by the horrendous fall in Garena's performance over the last few quarters. Fortunately, things seem to have turned for the better lately. As a start, QAU has stabilized after hitting a low in the fourth quarter of 2022. It further increased to 544 million in the third quarter of 2023. More importantly, Garena had its first quarter-over-quarter booking increase in the last two years in the third quarter of 2023.Another note is that Garena remained profitable even as revenue and bookings fell in the last two years. For instance, adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) came to $234 million in the third quarter of 2023 on revenue of $446 million .While it's probably too early to declare victory, I'm hopeful for Garena to sustain, if not improve, its performance from here, especially as it is due to relaunch its flagship Freefire game in India.The upcoming Freefire relaunch in IndiaIndia was one of the most promising markets for Garena thanks to its massive population of more than 1.4 billion. Yet, the Indian government banned the Freefire apps in early 2022 as part of a broader ban on Chinese apps, including TikTok -- leaving the company confused and disappointed.While the regulators cited privacy concerns, most investors believed that the ban was due to Sea's association with Tencent -- the latter a significant shareholder in Sea -- even though Sea is a Singaporean company. The Singapore government had to intervene in the ban, asserting that Sea Limited is a Singaporean company.Fortunately, more than a year after the initial ban, Garena announced in August that Freefire would return to the Indian market, suggesting that the ban has been lifted. The gaming company will host its Indian data in an Indian cloud provider to meet data privacy requirements. It initially planned to launch the game in September but postponed the launch -- date not announced yet -- to refine gameplay and improve localization .As a shareholder, I'm hopeful that Garena can successfully relaunch Freefire shortly. Still, investors should remain patient since the company would take a while to build up its user base in India, and monetization would come even later.What it means for investorsAfter a massive decline in revenue and profitability, Garena seems to have found a floor lately. QAU has stabilized, and bookings have grown again. Moreover, the reentry into the Indian market could give Garena the boost it badly needed to rekindle growth thanks to the enormous opportunity in a country with such a large population.The next few quarters will be crucial for Garena to prove that its recent performance is sustainable and that a recovery is ongoing. Investors should closely monitor key metrics such as bookings, MAU, and average revenue per user in the coming quarters.","news_type":1,"symbols_score_info":{"SE":0.9}},"isVote":1,"tweetType":1,"viewCount":2161,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9052316038,"gmtCreate":1655125366124,"gmtModify":1676535565744,"author":{"id":"3578983795474363","authorId":"3578983795474363","name":"DesmondChin","avatar":"https://static.tigerbbs.com/b90cb6b6a6c328ac8d02a829e5e7c835","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578983795474363","idStr":"3578983795474363"},"themes":[],"htmlText":"Just went into their livestreaming channel, 100k+ viewers at all time and their fans subscriptions had passed 15mil","listText":"Just went into their livestreaming channel, 100k+ viewers at all time and their fans subscriptions had passed 15mil","text":"Just went into their livestreaming channel, 100k+ viewers at all time and their fans subscriptions had passed 15mil","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9052316038","repostId":"2243688664","repostType":2,"isVote":1,"tweetType":1,"viewCount":2343,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9024461637,"gmtCreate":1653909415929,"gmtModify":1676535361019,"author":{"id":"3578983795474363","authorId":"3578983795474363","name":"DesmondChin","avatar":"https://static.tigerbbs.com/b90cb6b6a6c328ac8d02a829e5e7c835","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578983795474363","idStr":"3578983795474363"},"themes":[],"htmlText":"Lol crap, good day for Chinese ADRs but the market closed..","listText":"Lol crap, good day for Chinese ADRs but the market closed..","text":"Lol crap, good day for Chinese ADRs but the market closed..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9024461637","repostId":"1117585024","repostType":4,"repost":{"id":"1117585024","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1653467665,"share":"https://ttm.financial/m/news/1117585024?lang=&edition=fundamental","pubTime":"2022-05-25 16:34","market":"us","language":"en","title":"Reminder: U.S. Market Will Be Closed on May 30 for Memorial Day","url":"https://stock-news.laohu8.com/highlight/detail?id=1117585024","media":"Tiger Newspress","summary":"Memorial Day is around the corner. The U.S. market will be closed on Monday, 30 May 2022. Please tak","content":"<html><head></head><body><p>Memorial Day is around the corner. The U.S. market will be closed on Monday, 30 May 2022. Please take note of the trading arrangements during the holiday period and make the necessary preparations in advance.</p><p><img src=\"https://static.tigerbbs.com/e13ae8dcb177be8ec4a2157f685b9556\" tg-width=\"1080\" tg-height=\"1080\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Reminder: U.S. Market Will Be Closed on May 30 for Memorial Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReminder: U.S. Market Will Be Closed on May 30 for Memorial Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-05-25 16:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Memorial Day is around the corner. The U.S. market will be closed on Monday, 30 May 2022. Please take note of the trading arrangements during the holiday period and make the necessary preparations in advance.</p><p><img src=\"https://static.tigerbbs.com/e13ae8dcb177be8ec4a2157f685b9556\" tg-width=\"1080\" tg-height=\"1080\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117585024","content_text":"Memorial Day is around the corner. The U.S. market will be closed on Monday, 30 May 2022. Please take note of the trading arrangements during the holiday period and make the necessary preparations in advance.","news_type":1,"symbols_score_info":{".IXIC":0.9,".DJI":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":2237,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":861084673,"gmtCreate":1632442868992,"gmtModify":1676530783143,"author":{"id":"3578983795474363","authorId":"3578983795474363","name":"DesmondChin","avatar":"https://static.tigerbbs.com/b90cb6b6a6c328ac8d02a829e5e7c835","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578983795474363","idStr":"3578983795474363"},"themes":[],"htmlText":"Chances are high since we experience it once before ","listText":"Chances are high since we experience it once before ","text":"Chances are high since we experience it once before","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/861084673","repostId":"2169869550","repostType":4,"isVote":1,"tweetType":1,"viewCount":2936,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":863693494,"gmtCreate":1632382131018,"gmtModify":1676530768544,"author":{"id":"3578983795474363","authorId":"3578983795474363","name":"DesmondChin","avatar":"https://static.tigerbbs.com/b90cb6b6a6c328ac8d02a829e5e7c835","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578983795474363","idStr":"3578983795474363"},"themes":[],"htmlText":"Apple was and would still be a big bully. But in this case, fully support what apple did you can't just come to someone house and demand/do whatever you want, this is not freedom/freewill but act of hooligan ","listText":"Apple was and would still be a big bully. But in this case, fully support what apple did you can't just come to someone house and demand/do whatever you want, this is not freedom/freewill but act of hooligan ","text":"Apple was and would still be a big bully. But in this case, fully support what apple did you can't just come to someone house and demand/do whatever you want, this is not freedom/freewill but act of hooligan","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/863693494","repostId":"1167090659","repostType":4,"isVote":1,"tweetType":1,"viewCount":1954,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":863399070,"gmtCreate":1632356754690,"gmtModify":1676530760507,"author":{"id":"3578983795474363","authorId":"3578983795474363","name":"DesmondChin","avatar":"https://static.tigerbbs.com/b90cb6b6a6c328ac8d02a829e5e7c835","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578983795474363","idStr":"3578983795474363"},"themes":[],"htmlText":"New kid on the block","listText":"New kid on the block","text":"New kid on the block","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/863399070","repostId":"1153095874","repostType":4,"repost":{"id":"1153095874","kind":"news","pubTimestamp":1632353773,"share":"https://ttm.financial/m/news/1153095874?lang=&edition=fundamental","pubTime":"2021-09-23 07:36","market":"us","language":"en","title":"Salesforce rival Freshworks valued at over $12 billion as shares jump in U.S. debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1153095874","media":"Reuters","summary":"Enterprise software maker Freshworks Inc was valued at $12.2 billion in its Nasdaq debut on Wednesda","content":"<p>Enterprise software maker Freshworks Inc was valued at $12.2 billion in its Nasdaq debut on Wednesday after shares opened 21% above the initial offering price, indicating strong demand for firms that have thrived during the pandemic.</p>\n<p>Shares of the Salesforce.com rival opened at $43.50 compared with the IPO price of $36 per share. Freshworks joins a wave of tech listings this week, as the company sees higher demand from customers embracing the hybrid work model.</p>\n<p>Founded in the Indian city of Chennai, Freshworks has a suite of products that helps businesses with customer management, such as a messaging platform and an artificial-intelligence powered chatbot for customer support.</p>\n<p>“Our products are even more relevant today in the post pandemic world”, said Girish Mathrubootham, chief executive at Freshworks. “Every business wants to engage better with their customers through online digital channels, and they want to enable their employees to work from home.”</p>\n<p>The listing is also widely celebrated by the tech community in India, who sees Freshworks as the first homegrown software as a service (SaaS) company to go public in the U.S.</p>\n<p>“Freshworks could be the torchbearer for a whole new generation of entrepreneurs in India. We think that there’s embedded product and tech talent and entrepreneurs everywhere,” said Sameer Gandhi, partner at Accel, an early investor in Freshworks.</p>\n<p>Founded by Girish Mathrubootham and Shan Krishnasamy, Freshworks raised its first round of funds in 2011 and got its first customer, the Atwell College in Australia, in the same year. Its backers include Sequoia Capital and Tiger Global Management.</p>\n<p>San Mateo, California-headquartered Freshworks said it serves more than 50,000 companies, including high-profile names such as Delivery Hero SE, Swedish payments firm Klarna and Cisco Systems.</p>\n<p>On Tuesday night, the company priced its IPO above the top end of the range to raise $1.03 billion.</p>\n<p>Morgan Stanley, J.P. Morgan and BofA Securities were the lead underwriters for the offering.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Salesforce rival Freshworks valued at over $12 billion as shares jump in U.S. debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSalesforce rival Freshworks valued at over $12 billion as shares jump in U.S. debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-23 07:36 GMT+8 <a href=https://www.reuters.com/article/freshworks-ipo/update-3-salesforce-rival-freshworks-valued-at-over-12-bln-as-shares-jump-in-u-s-debut-idUSL4N2QO36J><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Enterprise software maker Freshworks Inc was valued at $12.2 billion in its Nasdaq debut on Wednesday after shares opened 21% above the initial offering price, indicating strong demand for firms that ...</p>\n\n<a href=\"https://www.reuters.com/article/freshworks-ipo/update-3-salesforce-rival-freshworks-valued-at-over-12-bln-as-shares-jump-in-u-s-debut-idUSL4N2QO36J\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRM":"赛富时","FRSH":"Freshworks"},"source_url":"https://www.reuters.com/article/freshworks-ipo/update-3-salesforce-rival-freshworks-valued-at-over-12-bln-as-shares-jump-in-u-s-debut-idUSL4N2QO36J","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153095874","content_text":"Enterprise software maker Freshworks Inc was valued at $12.2 billion in its Nasdaq debut on Wednesday after shares opened 21% above the initial offering price, indicating strong demand for firms that have thrived during the pandemic.\nShares of the Salesforce.com rival opened at $43.50 compared with the IPO price of $36 per share. Freshworks joins a wave of tech listings this week, as the company sees higher demand from customers embracing the hybrid work model.\nFounded in the Indian city of Chennai, Freshworks has a suite of products that helps businesses with customer management, such as a messaging platform and an artificial-intelligence powered chatbot for customer support.\n“Our products are even more relevant today in the post pandemic world”, said Girish Mathrubootham, chief executive at Freshworks. “Every business wants to engage better with their customers through online digital channels, and they want to enable their employees to work from home.”\nThe listing is also widely celebrated by the tech community in India, who sees Freshworks as the first homegrown software as a service (SaaS) company to go public in the U.S.\n“Freshworks could be the torchbearer for a whole new generation of entrepreneurs in India. We think that there’s embedded product and tech talent and entrepreneurs everywhere,” said Sameer Gandhi, partner at Accel, an early investor in Freshworks.\nFounded by Girish Mathrubootham and Shan Krishnasamy, Freshworks raised its first round of funds in 2011 and got its first customer, the Atwell College in Australia, in the same year. Its backers include Sequoia Capital and Tiger Global Management.\nSan Mateo, California-headquartered Freshworks said it serves more than 50,000 companies, including high-profile names such as Delivery Hero SE, Swedish payments firm Klarna and Cisco Systems.\nOn Tuesday night, the company priced its IPO above the top end of the range to raise $1.03 billion.\nMorgan Stanley, J.P. Morgan and BofA Securities were the lead underwriters for the offering.","news_type":1,"symbols_score_info":{"CRM":0.9,"FRSH":0.9}},"isVote":1,"tweetType":1,"viewCount":2432,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3581980965309451","authorId":"3581980965309451","name":"Eded","avatar":"https://static.tigerbbs.com/41a629a3014601072ee8dc2d151d1796","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"3581980965309451","idStr":"3581980965309451"},"content":"Can put into watchlist","text":"Can put into watchlist","html":"Can put into watchlist"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":863307398,"gmtCreate":1632356675814,"gmtModify":1676530760451,"author":{"id":"3578983795474363","authorId":"3578983795474363","name":"DesmondChin","avatar":"https://static.tigerbbs.com/b90cb6b6a6c328ac8d02a829e5e7c835","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578983795474363","idStr":"3578983795474363"},"themes":[],"htmlText":"The whole industry FM said bubble and you say no.... Well, you really one of a kind","listText":"The whole industry FM said bubble and you say no.... Well, you really one of a kind","text":"The whole industry FM said bubble and you say no.... Well, you really one of a kind","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/863307398","repostId":"2169668436","repostType":4,"isVote":1,"tweetType":1,"viewCount":3214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860255769,"gmtCreate":1632184283651,"gmtModify":1676530719461,"author":{"id":"3578983795474363","authorId":"3578983795474363","name":"DesmondChin","avatar":"https://static.tigerbbs.com/b90cb6b6a6c328ac8d02a829e5e7c835","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578983795474363","idStr":"3578983795474363"},"themes":[],"htmlText":"Safe for 5-11 but I have another kid at 2...","listText":"Safe for 5-11 but I have another kid at 2...","text":"Safe for 5-11 but I have another kid at 2...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860255769","repostId":"2168688448","repostType":4,"repost":{"id":"2168688448","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1632181503,"share":"https://ttm.financial/m/news/2168688448?lang=&edition=fundamental","pubTime":"2021-09-21 07:45","market":"us","language":"en","title":"Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in kids","url":"https://stock-news.laohu8.com/highlight/detail?id=2168688448","media":"Reuters","summary":"Sept 20 (Reuters) - Pfizer Inc and BioNTech SE said on Monday their COVID-19 vaccine induced a robus","content":"<p>Sept 20 (Reuters) - Pfizer Inc and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> said on Monday their COVID-19 vaccine induced a robust immune response in 5 to 11 year olds, and they plan to ask for regulatory authorization as soon as possible to use the shot in children in that age range in the United States, Europe and elsewhere.</p>\n<p>The companies said their two-dose vaccine generated an immune response in the 5-to-11 year olds in a Phase II/III clinical trial that matched what was previously observed in 16-to-25 year olds. The safety profile was also generally comparable to the older age group, they added.</p>\n<p>\"Since July, pediatric cases of COVID-19 have risen by about 240 percent in the U.S. - underscoring the public health need for vaccination,\" Pfizer Chief Executive Albert Bourla said in a news release.</p>\n<p>\"These trial results provide a strong foundation for seeking authorization of our vaccine for children 5 to 11 years old, and we plan to submit them to the FDA and other regulators with urgency,\" Bourla added.</p>\n<p>The Pfizer/BioNTech vaccine already has won U.S. regulatory authorization for people age 12 and up, including full Food and Drug Administration approval last month for ages 16 and up.</p>\n<p>Top U.S. health officials believe regulators could make a decision on whether the shot is safe and effective in younger children within three weeks of the companies submitting a request for authorization, two sources told Reuters this month. A rapid authorization could help mitigate a potential surge of cases this fall, with schools already open nationwide.</p>\n<p>COVID-19 hospitalizations and deaths have surged in the United States in recent months due to the highly contagious Delta variant, especially in areas with low vaccination rates even as President Joe Biden implores vaccine holdouts to get their shots. Pediatric cases are also up, particularly as children under 12 are all unvaccinated, but there is no indication that, beyond being more transmissible, the Delta virus is more dangerous in kids.</p>\n<p>FDA acting Commissioner Janet Woodcock said that once the agency receives the application, its process for determining if the vaccine is safe and effective for children in the younger age group includes verifying the manufacturing processes for the lower concentrations of the shots and any study of its safety.</p>\n<p>\"We'll look at the clinical data and make sure that children responded to the vaccine the way we would expect,\" Woodcock said during an appearance on former Biden administration official Andy Slavitt's podcast.</p>\n<p>Pfizer shares fell 1.3% to $43.28 before the bell on Monday amid broader market weakness.</p>\n<p>DATA FOR YOUNGER CHILDREN</p>\n<p>The Pfizer/BioNTech vaccine, called Comirnaty, is authorized for use in children as young as 12 in many countries in addition to the United States. It was originally authorized for emergency use in people 16 or older in the United States in December 2020.</p>\n<p>The 5-to-11 year olds were given two shots of a 10-microgram dose of the vaccine, a third the dose size given to people 12 and older.</p>\n<p>In addition, the companies said they expect data on how well the vaccine works in children ages 2-to-5 years and children ages 6 months-to-2 years as soon as the fourth quarter of this year.</p>\n<p>Unlike the larger clinical trial that the drugmakers previously conducted in adults, the 2,268-participant pediatric trial was not primarily designed to measure the vaccine's efficacy by comparing the number of COVID-19 cases in vaccine recipients to those who received a placebo.</p>\n<p>Instead, it compares the amount of neutralizing antibodies induced by the vaccine in the children to the response of older recipients in the adult trial.</p>\n<p>A Pfizer spokesperson said the companies may later disclose vaccine efficacy from the trial but there have not been enough cases of COVID-19 yet among the participants to make that determination.</p>\n<p>The vaccine was around 95 percent effective in the adult clinical trial, but Pfizer has said that immunity wanes some months after the second dose. U.S. regulators are expected to authorize a third, booster dose of the vaccine for older and high-risk Americans early this week.</p>\n<p>The companies said the vaccine was well-tolerated, with side effects generally comparable to those observed in participants 16 to 25 years of age.</p>\n<p>The Pfizer/BioNTech vaccine is one of three shots authorized in the United States, along with Moderna's two-dose vaccine and Johnson and Johnson's one-dose shot. The Moderna and J&J shots have not yet received full FDA approval for any age groups.</p>\n<p>Both the Pfizer and Moderna vaccines have been linked by regulators to rare cases of heart inflammation in adolescents and young adults, particularly young men. Pfizer said they did not see any instances of heart inflammation in the trial participants.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in kids</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer/BioNTech say data show COVID-19 vaccine safe and protective in kids\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-21 07:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sept 20 (Reuters) - Pfizer Inc and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> said on Monday their COVID-19 vaccine induced a robust immune response in 5 to 11 year olds, and they plan to ask for regulatory authorization as soon as possible to use the shot in children in that age range in the United States, Europe and elsewhere.</p>\n<p>The companies said their two-dose vaccine generated an immune response in the 5-to-11 year olds in a Phase II/III clinical trial that matched what was previously observed in 16-to-25 year olds. The safety profile was also generally comparable to the older age group, they added.</p>\n<p>\"Since July, pediatric cases of COVID-19 have risen by about 240 percent in the U.S. - underscoring the public health need for vaccination,\" Pfizer Chief Executive Albert Bourla said in a news release.</p>\n<p>\"These trial results provide a strong foundation for seeking authorization of our vaccine for children 5 to 11 years old, and we plan to submit them to the FDA and other regulators with urgency,\" Bourla added.</p>\n<p>The Pfizer/BioNTech vaccine already has won U.S. regulatory authorization for people age 12 and up, including full Food and Drug Administration approval last month for ages 16 and up.</p>\n<p>Top U.S. health officials believe regulators could make a decision on whether the shot is safe and effective in younger children within three weeks of the companies submitting a request for authorization, two sources told Reuters this month. A rapid authorization could help mitigate a potential surge of cases this fall, with schools already open nationwide.</p>\n<p>COVID-19 hospitalizations and deaths have surged in the United States in recent months due to the highly contagious Delta variant, especially in areas with low vaccination rates even as President Joe Biden implores vaccine holdouts to get their shots. Pediatric cases are also up, particularly as children under 12 are all unvaccinated, but there is no indication that, beyond being more transmissible, the Delta virus is more dangerous in kids.</p>\n<p>FDA acting Commissioner Janet Woodcock said that once the agency receives the application, its process for determining if the vaccine is safe and effective for children in the younger age group includes verifying the manufacturing processes for the lower concentrations of the shots and any study of its safety.</p>\n<p>\"We'll look at the clinical data and make sure that children responded to the vaccine the way we would expect,\" Woodcock said during an appearance on former Biden administration official Andy Slavitt's podcast.</p>\n<p>Pfizer shares fell 1.3% to $43.28 before the bell on Monday amid broader market weakness.</p>\n<p>DATA FOR YOUNGER CHILDREN</p>\n<p>The Pfizer/BioNTech vaccine, called Comirnaty, is authorized for use in children as young as 12 in many countries in addition to the United States. It was originally authorized for emergency use in people 16 or older in the United States in December 2020.</p>\n<p>The 5-to-11 year olds were given two shots of a 10-microgram dose of the vaccine, a third the dose size given to people 12 and older.</p>\n<p>In addition, the companies said they expect data on how well the vaccine works in children ages 2-to-5 years and children ages 6 months-to-2 years as soon as the fourth quarter of this year.</p>\n<p>Unlike the larger clinical trial that the drugmakers previously conducted in adults, the 2,268-participant pediatric trial was not primarily designed to measure the vaccine's efficacy by comparing the number of COVID-19 cases in vaccine recipients to those who received a placebo.</p>\n<p>Instead, it compares the amount of neutralizing antibodies induced by the vaccine in the children to the response of older recipients in the adult trial.</p>\n<p>A Pfizer spokesperson said the companies may later disclose vaccine efficacy from the trial but there have not been enough cases of COVID-19 yet among the participants to make that determination.</p>\n<p>The vaccine was around 95 percent effective in the adult clinical trial, but Pfizer has said that immunity wanes some months after the second dose. U.S. regulators are expected to authorize a third, booster dose of the vaccine for older and high-risk Americans early this week.</p>\n<p>The companies said the vaccine was well-tolerated, with side effects generally comparable to those observed in participants 16 to 25 years of age.</p>\n<p>The Pfizer/BioNTech vaccine is one of three shots authorized in the United States, along with Moderna's two-dose vaccine and Johnson and Johnson's one-dose shot. The Moderna and J&J shots have not yet received full FDA approval for any age groups.</p>\n<p>Both the Pfizer and Moderna vaccines have been linked by regulators to rare cases of heart inflammation in adolescents and young adults, particularly young men. Pfizer said they did not see any instances of heart inflammation in the trial participants.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞","BNTX":"BioNTech SE","JNJ":"强生"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168688448","content_text":"Sept 20 (Reuters) - Pfizer Inc and BioNTech SE said on Monday their COVID-19 vaccine induced a robust immune response in 5 to 11 year olds, and they plan to ask for regulatory authorization as soon as possible to use the shot in children in that age range in the United States, Europe and elsewhere.\nThe companies said their two-dose vaccine generated an immune response in the 5-to-11 year olds in a Phase II/III clinical trial that matched what was previously observed in 16-to-25 year olds. The safety profile was also generally comparable to the older age group, they added.\n\"Since July, pediatric cases of COVID-19 have risen by about 240 percent in the U.S. - underscoring the public health need for vaccination,\" Pfizer Chief Executive Albert Bourla said in a news release.\n\"These trial results provide a strong foundation for seeking authorization of our vaccine for children 5 to 11 years old, and we plan to submit them to the FDA and other regulators with urgency,\" Bourla added.\nThe Pfizer/BioNTech vaccine already has won U.S. regulatory authorization for people age 12 and up, including full Food and Drug Administration approval last month for ages 16 and up.\nTop U.S. health officials believe regulators could make a decision on whether the shot is safe and effective in younger children within three weeks of the companies submitting a request for authorization, two sources told Reuters this month. A rapid authorization could help mitigate a potential surge of cases this fall, with schools already open nationwide.\nCOVID-19 hospitalizations and deaths have surged in the United States in recent months due to the highly contagious Delta variant, especially in areas with low vaccination rates even as President Joe Biden implores vaccine holdouts to get their shots. Pediatric cases are also up, particularly as children under 12 are all unvaccinated, but there is no indication that, beyond being more transmissible, the Delta virus is more dangerous in kids.\nFDA acting Commissioner Janet Woodcock said that once the agency receives the application, its process for determining if the vaccine is safe and effective for children in the younger age group includes verifying the manufacturing processes for the lower concentrations of the shots and any study of its safety.\n\"We'll look at the clinical data and make sure that children responded to the vaccine the way we would expect,\" Woodcock said during an appearance on former Biden administration official Andy Slavitt's podcast.\nPfizer shares fell 1.3% to $43.28 before the bell on Monday amid broader market weakness.\nDATA FOR YOUNGER CHILDREN\nThe Pfizer/BioNTech vaccine, called Comirnaty, is authorized for use in children as young as 12 in many countries in addition to the United States. It was originally authorized for emergency use in people 16 or older in the United States in December 2020.\nThe 5-to-11 year olds were given two shots of a 10-microgram dose of the vaccine, a third the dose size given to people 12 and older.\nIn addition, the companies said they expect data on how well the vaccine works in children ages 2-to-5 years and children ages 6 months-to-2 years as soon as the fourth quarter of this year.\nUnlike the larger clinical trial that the drugmakers previously conducted in adults, the 2,268-participant pediatric trial was not primarily designed to measure the vaccine's efficacy by comparing the number of COVID-19 cases in vaccine recipients to those who received a placebo.\nInstead, it compares the amount of neutralizing antibodies induced by the vaccine in the children to the response of older recipients in the adult trial.\nA Pfizer spokesperson said the companies may later disclose vaccine efficacy from the trial but there have not been enough cases of COVID-19 yet among the participants to make that determination.\nThe vaccine was around 95 percent effective in the adult clinical trial, but Pfizer has said that immunity wanes some months after the second dose. U.S. regulators are expected to authorize a third, booster dose of the vaccine for older and high-risk Americans early this week.\nThe companies said the vaccine was well-tolerated, with side effects generally comparable to those observed in participants 16 to 25 years of age.\nThe Pfizer/BioNTech vaccine is one of three shots authorized in the United States, along with Moderna's two-dose vaccine and Johnson and Johnson's one-dose shot. The Moderna and J&J shots have not yet received full FDA approval for any age groups.\nBoth the Pfizer and Moderna vaccines have been linked by regulators to rare cases of heart inflammation in adolescents and young adults, particularly young men. Pfizer said they did not see any instances of heart inflammation in the trial participants.","news_type":1,"symbols_score_info":{"BNTX":0.9,"PFE":0.9,"JNJ":0.9,"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":1790,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860252351,"gmtCreate":1632184210573,"gmtModify":1676530719422,"author":{"id":"3578983795474363","authorId":"3578983795474363","name":"DesmondChin","avatar":"https://static.tigerbbs.com/b90cb6b6a6c328ac8d02a829e5e7c835","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578983795474363","idStr":"3578983795474363"},"themes":[],"htmlText":"Overhyped stock","listText":"Overhyped stock","text":"Overhyped stock","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/860252351","repostId":"1164165591","repostType":4,"isVote":1,"tweetType":1,"viewCount":2373,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860258566,"gmtCreate":1632184115055,"gmtModify":1676530719381,"author":{"id":"3578983795474363","authorId":"3578983795474363","name":"DesmondChin","avatar":"https://static.tigerbbs.com/b90cb6b6a6c328ac8d02a829e5e7c835","crmLevel":11,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3578983795474363","idStr":"3578983795474363"},"themes":[],"htmlText":"Lol, anything bout gambling then MJ would be keen","listText":"Lol, anything bout gambling then MJ would be keen","text":"Lol, anything bout gambling then MJ would be keen","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860258566","repostId":"2169681422","repostType":4,"isVote":1,"tweetType":1,"viewCount":1981,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}